In this section

Research

Biological systems - including the simplest cells - exhibit a broad range of functions to thrive in their environment. Research in the Imperial College Centre for Synthetic Biology is focused on the possibility of engineering the underlying biochemical processes to solve many of the challenges facing society, from healthcare to sustainable energy. In particular, we model, analyse, design and build biological and biochemical systems in living cells and/or in cell extracts, both exploring and enhancing the engineering potential of biology.

As part of our research we develop novel methods to accelerate the celebrated Design-Build-Test-Learn synthetic biology cycle. As such research in the Centre for Synthetic Biology highly multi- and interdisciplinary covering computational modelling and machine learning approaches; automated platform development and genetic circuit engineering ; multi-cellular and multi-organismal interactions, including gene drive and genome engineering; metabolic engineering; in vitro/cell-free synthetic biology; engineered phages and directed evolution; and biomimetics, biomaterials and biological engineering.

Publications

Citation

BibTex format

@article{Goers:2017:10.1002/bit.26254,
author = {Goers, L and Ainsworth, C and Goey, CH and Kontoravdi and Freemont, PS and Polizzi, KM},
doi = {10.1002/bit.26254},
journal = {Biotechnology and Bioengineering},
pages = {1290--1300},
title = {Whole-cell Escherichia coli lactate biosensor for monitoring mammalian cell cultures during biopharmaceutical production},
url = {http://dx.doi.org/10.1002/bit.26254},
volume = {114},
year = {2017}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Many high-value added recombinant proteins, such as therapeutic glycoproteins, are produced using mammalian cell cultures. In order to optimise the productivity of these cultures it is important to monitor cellular metabolism, for example the utilisation of nutrients and the accumulation of metabolic waste products. One metabolic waste product of interest is lactic acid (lactate), overaccumulation of which can decrease cellular growth and protein production. Current methods for the detection of lactate are limited in terms of cost, sensitivity, and robustness. Therefore, we developed a whole-cell Escherichia coli lactate biosensor based on the lldPRD operon and successfully used it to monitor lactate concentration in mammalian cell cultures. Using real samples and analytical validation we demonstrate that our biosensor can be used for absolute quantification of metabolites in complex samples with high accuracy, sensitivity and robustness. Importantly, our whole-cell biosensor was able to detect lactate at concentrations more than two orders of magnitude lower than the industry standard method, making it useful for monitoring lactate concentrations in early phase culture. Given the importance of lactate in a variety of both industrial and clinical contexts we anticipate that our whole-cell biosensor can be used to address a range of interesting biological questions. It also serves as a blueprint for how to capitalise on the wealth of genetic operons for metabolite sensing available in Nature for the development of other whole-cell biosensors.
AU  - Goers,L
AU  - Ainsworth,C
AU  - Goey,CH
AU  - Kontoravdi
AU  - Freemont,PS
AU  - Polizzi,KM
DO  - 10.1002/bit.26254
EP  - 1300
PY  - 2017///
SN  - 1097-0290
SP  - 1290
TI  - Whole-cell Escherichia coli lactate biosensor for monitoring mammalian cell cultures during biopharmaceutical production
T2  - Biotechnology and Bioengineering
UR  - http://dx.doi.org/10.1002/bit.26254
UR  - http://hdl.handle.net/10044/1/44165
VL  - 114
ER  -